Beryl Crossley

1.2k total citations
22 papers, 796 citations indexed

About

Beryl Crossley is a scholar working on Pediatrics, Perinatology and Child Health, Genetics and Genetics. According to data from OpenAlex, Beryl Crossley has authored 22 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pediatrics, Perinatology and Child Health, 5 papers in Genetics and 4 papers in Genetics. Recurrent topics in Beryl Crossley's work include Prenatal Screening and Diagnostics (3 papers), Genetics and Neurodevelopmental Disorders (3 papers) and Cystic Fibrosis Research Advances (3 papers). Beryl Crossley is often cited by papers focused on Prenatal Screening and Diagnostics (3 papers), Genetics and Neurodevelopmental Disorders (3 papers) and Cystic Fibrosis Research Advances (3 papers). Beryl Crossley collaborates with scholars based in United States and United Kingdom. Beryl Crossley's co-authors include M G W Kettlewell, R G Souter, Janet E. Price, Weimin Sun, Franklin Quan, Charles M. Strom, Joy B. Redman, Charles M. Strom, Arlene Buller and Ben Anderson and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Clinical Pathology.

In The Last Decade

Beryl Crossley

22 papers receiving 767 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beryl Crossley United States 13 240 181 170 152 129 22 796
L Perroni Italy 17 184 0.8× 587 3.2× 302 1.8× 80 0.5× 53 0.4× 39 2.1k
Katsuya Yamamoto Japan 20 202 0.8× 54 0.3× 358 2.1× 46 0.3× 89 0.7× 102 1.1k
F. Ann Hayes United States 9 322 1.3× 62 0.3× 247 1.5× 140 0.9× 154 1.2× 12 980
Catharina Dhooge Belgium 17 230 1.0× 74 0.4× 214 1.3× 53 0.3× 238 1.8× 49 1.0k
Magan Trottier United States 10 125 0.5× 114 0.6× 193 1.1× 26 0.2× 53 0.4× 17 572
Charlotte A. Brown United States 22 170 0.7× 124 0.7× 489 2.9× 71 0.5× 26 0.2× 44 1.0k
Victoria Bedell United States 16 181 0.8× 129 0.7× 431 2.5× 57 0.4× 153 1.2× 40 1.0k
Cheryl L. Hardy United States 19 245 1.0× 127 0.7× 178 1.0× 115 0.8× 37 0.3× 44 861
Pamela J. Reitnauer United States 11 249 1.0× 395 2.2× 539 3.2× 39 0.3× 46 0.4× 20 1.1k
James Wang United States 14 163 0.7× 59 0.3× 277 1.6× 97 0.6× 40 0.3× 49 903

Countries citing papers authored by Beryl Crossley

Since Specialization
Citations

This map shows the geographic impact of Beryl Crossley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beryl Crossley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beryl Crossley more than expected).

Fields of papers citing papers by Beryl Crossley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beryl Crossley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beryl Crossley. The network helps show where Beryl Crossley may publish in the future.

Co-authorship network of co-authors of Beryl Crossley

This figure shows the co-authorship network connecting the top 25 collaborators of Beryl Crossley. A scholar is included among the top collaborators of Beryl Crossley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beryl Crossley. Beryl Crossley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Lik Wee, Shahin Shafiani, Beryl Crossley, et al.. (2022). Characterisation of T cell receptor repertoires in coeliac disease. Journal of Clinical Pathology. 77(2). 116–124. 3 indexed citations
2.
Tong, Christopher, et al.. (2021). A review of guidelines for evaluating a minor modification to a validated assay. Revue Scientifique et Technique de l OIE. 40(1). 217–226. 3 indexed citations
3.
Wood, Brent L., David Wu, Beryl Crossley, et al.. (2017). Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL. Blood. 131(12). 1350–1359. 130 indexed citations
4.
Sanders, Heather, Hairong Li, Lin Ma, et al.. (2016). Mutation Yield of a 34-Gene Solid Tumor Panel in Community-Based Tumor Samples. Molecular Diagnosis & Therapy. 20(3). 241–253. 1 indexed citations
6.
Strom, Charles M., Beryl Crossley, Ke Zhang, et al.. (2012). Testing for variants in CYP2C19: population frequencies and testing experience in a clinical laboratory. Genetics in Medicine. 14(1). 95–100. 64 indexed citations
7.
Strom, Charles M., Ke Zhang, Kevin J. Doody, et al.. (2012). The sensitivity and specificity of hyperglycosylated hCG (hhCG) levels to reliably diagnose clinical IVF pregnancies at 6 days following embryo transfer. Journal of Assisted Reproduction and Genetics. 29(7). 609–614. 12 indexed citations
8.
Strom, Charles M., Beryl Crossley, Ke Zhang, et al.. (2011). Testing for variants in CYP2C19: Population frequencies and testing experience in a clinical laboratory. Genetics in Medicine. 1–1. 6 indexed citations
10.
Strom, Charles M., Beryl Crossley, Michael Jarvis, et al.. (2010). Cystic fibrosis testing 8 years on: Lessons learned from carrier screening and sequencing analysis. Genetics in Medicine. 13(2). 166–172. 37 indexed citations
11.
Strom, Charles M., Beryl Crossley, Joy B. Redman, et al.. (2007). Molecular testing for Fragile X Syndrome: Lessons learned from 119,232 tests performed in a clinical laboratory. Genetics in Medicine. 9(1). 46–51. 42 indexed citations
12.
McGinniss, Matthew J., Rebecca Chen, Victoria M. Pratt, et al.. (2007). Development of a Web-Based Query Tool for Quality Assurance of Clinical Molecular Genetic Test Results. Journal of Molecular Diagnostics. 9(1). 95–98. 2 indexed citations
13.
Potts, Sarah‐Jane, et al.. (2007). Clinical validation of a self-organizing map (SOM)-based quantitative prediction algorithm to determine the site of origin of cancers of unknown primary (CUP). Journal of Clinical Oncology. 25(18_suppl). 21064–21064. 1 indexed citations
14.
Brown, Nicholas M., Victoria M. Pratt, Arlene Buller, et al.. (2005). Detection of 677CT/1298AC “double variant” chromosomes: Implications for interpretation of MTHFR genotyping results. Genetics in Medicine. 7(4). 278–282. 16 indexed citations
15.
Strom, Charles M., Beryl Crossley, Joy B. Redman, et al.. (2004). Cystic fibrosis screening: Lessons learned from the first 320,000 patients. Genetics in Medicine. 6(3). 136–140. 24 indexed citations
16.
Strom, Charles M., Beryl Crossley, Joy B. Redman, et al.. (2004). Molecular screening for diseases frequent in Ashkenazi Jews: Lessons learned from more than 100,000 tests performed in a commercial laboratory. Genetics in Medicine. 6(3). 145–152. 28 indexed citations
17.
Strom, Charles M., Donghui Huang, Arlene Buller, et al.. (2002). Cystic fibrosis screening using the College panel: Platform comparison and lessons learned from the first 20,000 samples. Genetics in Medicine. 4(4). 289–296. 42 indexed citations
18.
Crossley, Beryl, A Heryet, & K C Gatter. (1987). Does nodular lymphocyte predominant Hodgkin's disease arise from progressively transformed germinal centres? A case report with an unusually prolonged history. Histopathology. 11(6). 621–630. 16 indexed citations
19.
Price, Janet E., et al.. (1984). Clinicopathological observations on metastasis in man studied in patients treated with peritoneovenous shunts.. BMJ. 288(6419). 749–751. 58 indexed citations
20.
Price, Janet E., et al.. (1984). Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts.. PubMed. 44(8). 3584–92. 219 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026